{"name":"SK Plasma Co., Ltd.","slug":"sk-plasma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LIV-GAMMA SN Inj.10%","genericName":"LIV-GAMMA SN Inj.10%","slug":"liv-gamma-sn-inj-10","indication":"Primary immunodeficiency disorders","status":"phase_3"}]},{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"SKP-0141","genericName":"SKP-0141","slug":"skp-0141","indication":"Hemophilia or other inherited bleeding disorders","status":"phase_3"}]}],"pipeline":[{"name":"LIV-GAMMA SN Inj.10%","genericName":"LIV-GAMMA SN Inj.10%","slug":"liv-gamma-sn-inj-10","phase":"phase_3","mechanism":"LIV-GAMMA SN is an intravenous immunoglobulin (IVIG) preparation that provides passive immunity by delivering pooled human antibodies to modulate immune responses.","indications":["Primary immunodeficiency disorders","Immune thrombocytopenia (ITP)","Chronic inflammatory demyelinating polyneuropathy (CIDP)","Kawasaki disease"],"catalyst":""},{"name":"SKP-0141","genericName":"SKP-0141","slug":"skp-0141","phase":"phase_3","mechanism":"SKP-0141 is a recombinant human albumin fusion protein designed to enhance hemostasis and reduce bleeding in patients with coagulation disorders.","indications":["Hemophilia or other inherited bleeding disorders"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOZ0NIajc1SUM4YVFHZno2b0tZcl9iTkVlTE9vckhneTAxcndxRGtHZWlmVkpLWjF4cmZaLUZGUjRpS0RNQnlya2hMQ2J1WHRBMk5GU2ZsbnFydGs2bWY0VEFZVWQ2b1BCeHBPbGhULVJtd29PNk15YWdfYzJqYnZ0Y9IBlAFBVV95cUxNMkpnb0NwQmZqZTZRbXdYaHRlWDhPbVROei1hWkk0V2V5QkMtS2hPQ0lKUGpfS21iVUliWGh2Y0VYMFBITHgxTlZJT1hnRUM4TkpWMDhubE9HcnZ1RjNkeDFSTHJPTzdSRl9DcDVmREUxTFBhckRyVms5LXZ4ZWloVjc1ckZSckMzOTdBZVVQVWZoNmt4?oc=5","date":"2026-01-12","type":"patent","source":"Chosunbiz","summary":"Rate cuts and patent expirations revive Korea bio IPO market - CHOSUNBIZ - Chosunbiz","headline":"Rate cuts and patent expirations revive Korea bio IPO market - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOSXp3TW1vTGk0VlB1eEJPVUliNjBldTJjcHprWHlVejRpY1U5REpMMEFhMmdqX203ZnBYUFFpbXVLam1Bdks2OFo5c2xzQkZoV1BTV2ZmMndfQklMLTVoWEw3Vlo5Yk9FYU9IMmktaUhWTW1ubEJybk1iQ2JnLU1QNXcwQVp5WHhBcFF0RFp2eUp5ZFJ3RDhCQkx6M2JJaFU1d2czR0lCNTBCcVBzSGxTdURha2RGNmdWZkE?oc=5","date":"2025-12-19","type":"pipeline","source":"Nikkei Asia","summary":"SK Plasma's Indonesia factory to mass produce blood-derived drugs in 2026 - Nikkei Asia","headline":"SK Plasma's Indonesia factory to mass produce blood-derived drugs in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxORW1qN2RJYnhkNlZBR1BhQUduZDFUaXF1SXhhWUl4MTR0MEFzSGlnS2xtaTFxQUZGS2RWVXJvZC1vRUdhdnpDaEtYVnRZbzNVbW5iOXZUeTNnTnJ4T3o1LTlwalRWWUNFdUxJaEM0TTlJaVlrdFNXeFVja2NJU1hRVmVn?oc=5","date":"2025-12-04","type":"pipeline","source":"BioWorld News","summary":"Aimedbio debuts with $48M Kosdaq IPO - BioWorld News","headline":"Aimedbio debuts with $48M Kosdaq IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPTnNVeElkQ3V6U1JkQVAzNFVCSkJlckFIcU4tdzNyV2hzUG1ySTJocDM0TmN3VVMtUlZqSW9sMXZOZ0FGQmNyV0QwNmFLRWdXRUxOQXh3NlNWaFZndTBXdzE2TzVMSEpMUWZBS2tiaDl4aGVmWldUbkZMeEhZU19OU2JvQVZQRGc3cTZZejNxQTB0UVpjZ25BelRPZks1d9IBowFBVV95cUxNMWdlYUM1cEJvNnUzNTJzQjUxQzJ1UUcyQnI5ZWdtZGVldUZNY1lRU0FVaGNZREFhNHNKWGF2eGotNDJId0hLZnNJQVNWUUJnbW5JQ25jQno0Q3hsR1BSWV9JRVAyQ2duTGdudlJVdDdSZDZOLTZ1d0t6dE8tV0p1UWIxVXBCSGs1MzN6MEZGZ1RBb20wR09qejRjOV9fc3p4UkFn?oc=5","date":"2025-10-31","type":"pipeline","source":"ANTARA News","summary":"Danantara, SK Plasma strengthen Indonesias health resilience - ANTARA News","headline":"Danantara, SK Plasma strengthen Indonesias health resilience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPVlo0UlJ3YmZfN1Foa3J1end3NHMyb0hXekVqQ0h3X2l6SVFwcnZlQkdGNXhqZzFGZWMwTUxxZkU5QTBZcUNGNDRheUIxWWVkMkZySm9qMXU0bnVadmVaMGRHdEF6RjU3SDJWM0VqNWQyaUJlUkNWY3puLUNIb1pSbk1HZEtBZFNkdmlkN1EzTmM4bjFkNkFpRHc0NjlZRnpWMDE1VGhkUzg?oc=5","date":"2025-06-17","type":"deal","source":"BioWorld News","summary":"Korea biotech roundup: four financings, six R&D deals mid-June - BioWorld News","headline":"Korea biotech roundup: four financings, six R&D deals mid-June","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTFBtNUdCTVloWHEyakJ2NWQ5UlFtNHpCWlo5NWctNVdxWEJJa1pOQ3g4bklYcEV6Q0lzTXd2M25LeUM3M2ludXhUWWdKWQ?oc=5","date":"2024-12-16","type":"pipeline","source":"매일경제","summary":"SK Plasma (CEO Kim Seung-joo), a blood product company, announced on the 16th that it has signed an - 매일경제","headline":"SK Plasma (CEO Kim Seung-joo), a blood product company, announced on the 16th that it has signed an - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5EU09KVVdQbHJSTmQ2SlJyaF9XMU9kQzVtRGJ1YS0xdU1vQ01QTlRWTzRIa2ZTMXJBUWIwS210Qmx3QXd0WkRHYVVtaXNveHV6VWVGNVc2UGNBLU0wSUdSZE41ajRLdXRFRVBBMURn0gFyQVVfeXFMTzA0a0hlY0dmRFU2b040M0Q3VzRQc29rbnZOaUV3UkM4blJDVHFnNHQySjM5UXl6VzV6NzhPNDRmZkVZZ0paZEktMVlJVzE3V3BGRjhFSzlMdnVUR2UySHVEUDRzcVE5Tm5zYkNuS21ibWhn?oc=5","date":"2024-11-15","type":"pipeline","source":"koreabiomed.com","summary":"SK plasma secures investment from Indonesia's sovereign wealth fund, plans blood product plant to boost self-sufficiency - koreabiomed.com","headline":"SK plasma secures investment from Indonesia's sovereign wealth fund, plans blood product plant to boost self-sufficiency","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAJBVV95cUxPdlJQX0VacnlHNlJVZGdTX1Jqc1lVeml0RVozdVhhalJBNWtFdGtUYUQzeWRudGJCMlB1Nmx2c05tN0ZFOXp1UVVwcG1Ia3JqRHYyQ0FtVmIxenkzWHFRYU5KNnhjeVpHWnpuUEYzRmVLS0lEWUxTWFlWSFVBd0l4MUhLTVRQZmdKb1JZa240amZyWmxSUElpZTZGZ0hMS1JxMllxQ2ZoWWd3M2VsZ2tGSEVCT2I3dnd3Qk5VSjFIV0JSblVnbFF6VVFDdnZIUFRqRWd1aFZnOVBnVWVzZ3pDbDMzSkFNRVVsc0tyRnZzRXpNQkpDaDE4Z1Ywa04wbnZyWTFCU3EyMXVTWjJuLVplOUprUWJUNGQyenZ0ZDc1RHE2VE5nX19ucXkxLWM4ODF2QTZ1MlZjUmltREZRc0R0MmwwcDJzaHNI?oc=5","date":"2024-10-31","type":"pipeline","source":"PR Newswire","summary":"Blood Plasma Market to Grow by USD 15.9 Billion (2024-2028) as Innovative Solutions Address Global Blood Shortage; Report Highlights AI's Impact on Market Trends - Technavio - PR Newswire","headline":"Blood Plasma Market to Grow by USD 15.9 Billion (2024-2028) as Innovative Solutions Address Global Blood Shortage; Repor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8tZ09HYnpHd29fRGIyWjJ5Ykh2aG5mc2hiN2hEeGVtQmZJU3pRVTBnZFNsM0IzWlloWXhrZjRrdC1FQ0lQMnEwUzdiOUNDN1Z3NVdBdFdiWWpUNHM2NDRyMnp3VndRcDh2eFB4b2Fn0gFyQVVfeXFMTlo2bEdwM3o4aHYtQmk3VnNDbzQzX0VGWXdvR1FlRjE3cjR4blo5WEFnV2ZxTHpoaHFacklZa04zYmx3TU5yaDV6aFR1STdKclRaVlZkcS00OGRGaGhOT1E2S3JGeEhHZm43ZGRMcFZpVnZB?oc=5","date":"2023-12-14","type":"pipeline","source":"koreabiomed.com","summary":"SK plasma ships 1st batch of $11.3 million contract manufacturing blood products to Singapore - koreabiomed.com","headline":"SK plasma ships 1st batch of $11.3 million contract manufacturing blood products to Singapore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5aQVY3dmVPbkc1Uk5lWm1zdThYbG5QTUFmWG96bjJtWEwwLVN5Z21oSldVT21Cd05LMk04SU5EN1VDOW43ZUYyMnJTaUxnLTBkQVFNbVA1Q25lZjZxSVE1RERnNXhobGo0QTZjanNR?oc=5","date":"2023-10-10","type":"pipeline","source":"KED Global","summary":"SK Plasma gets investment from Indonesian fund - KED Global","headline":"SK Plasma gets investment from Indonesian fund","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1fTWhSZEhiVlFPQ2g1UkwxSTZDVW41OElZLTEwTFdWaUw0aWpiOHJWeWRTVEdPcFpuRDhick56UVQxdUlMNzhka0kwMGtsOXpxalNBcVBEQzZLRlIzdHVuTjc1M3FoRnJ6WVBzZkRR?oc=5","date":"2023-06-28","type":"pipeline","source":"KED Global","summary":"SK Plasma to supply $30 mn in blood products to Singapore - KED Global","headline":"SK Plasma to supply $30 mn in blood products to Singapore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE4tTW5zVDg5d052TDhDNkN1ejNacDh2Y0taYlZ4bXFfNURDQVY4NVU2SUNvYXFKTHhmMmdqTTNRdlA0MFhCbHVIc1RtQWp1bU5GOHV5ZEdn?oc=5","date":"2020-02-11","type":"pipeline","source":"The Korea Herald","summary":"GC Pharma, SK Plasma going global to offset blood shortage - The Korea Herald","headline":"GC Pharma, SK Plasma going global to offset blood shortage","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}